Glucokinase (GK) plays a central role in glucose utilization by the liver and may couple the ambient glucose concentration to insulin secretion in the pancreatic beta-cell. These different functions require that GK be regulated independently in each tissue. GK activity in these two tissues is directly related to the rate of synthesis of the protein. Hepatic GK synthesis is increased by insulin and decreased by cAMP whereas glucose may regulate the beta-cell GK. Insulin increases hepatic GK transcription but similar studies have not been reported for the other effectors. There is no evidence of activity of the gene in tissues other than the liver and beta-cell, and we have evidence which shows that different promoters are used in these tissues. The studies in this proposal are designed to yield information about the hormonal regulation of the GK gene in the liver and beta cell, and about how the tissue specific expression of this gene is accomplished.
Three Specific Aims are proposed.
Aim 1 : """"""""How is the hepatic GK gene regulated?"""""""" concerns defining the cis-acting DNA elements and associated trans-acting proteins involved in basal and hormone regulated expression of GK in liver.
Aim 2 : """"""""How is the pancreatic beta-cell GK regulated"""""""" will address similar questions in these cells. In addition, we plan to compare the regulation of GK with that of the insulin gene, another beta-cell specific gene, to determine whether common DNA elements and factors are involved in their regulation.
Aim 3 : """"""""How is tissue specific regulation of the GK gene promoter accomplished"""""""" provides a complement to Aims 1 and 2.
This Aim will employ DNA transfection and transgenic techniques to address this fundamental question.

Project Start
Project End
Budget Start
Budget End
Support Year
3
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Zhang, Juliet; Weinrich, Jarret A P; Russ, Jeffrey B et al. (2017) A Role for Dystonia-Associated Genes in Spinal GABAergic Interneuron Circuitry. Cell Rep 21:666-678
Krah, Nathan M; De La O, Jean-Paul; Swift, Galvin H et al. (2015) The acinar differentiation determinant PTF1A inhibits initiation of pancreatic ductal adenocarcinoma. Elife 4:
Baeyens, Luc; Lemper, Marie; Leuckx, Gunter et al. (2014) Transient cytokine treatment induces acinar cell reprogramming and regenerates functional beta cell mass in diabetic mice. Nat Biotechnol 32:76-83
Liu, Jing; Willet, Spencer G; Bankaitis, Eric D et al. (2013) Non-parallel recombination limits Cre-LoxP-based reporters as precise indicators of conditional genetic manipulation. Genesis 51:436-42
Kopinke, Daniel; Brailsford, Marisa; Pan, Fong Cheng et al. (2012) Ongoing Notch signaling maintains phenotypic fidelity in the adult exocrine pancreas. Dev Biol 362:57-64
Gu, Yanyun; Lindner, Jill; Kumar, Anil et al. (2011) Rictor/mTORC2 is essential for maintaining a balance between beta-cell proliferation and cell size. Diabetes 60:827-37
Pound, Lynley D; Hang, Yan; Sarkar, Suparna A et al. (2011) The pancreatic islet ?-cell-enriched transcription factor Pdx-1 regulates Slc30a8 gene transcription through an intronic enhancer. Biochem J 433:95-105
Papizan, James B; Singer, Ruth A; Tschen, Shuen-Ing et al. (2011) Nkx2.2 repressor complex regulates islet ?-cell specification and prevents ?-to-?-cell reprogramming. Genes Dev 25:2291-305
Artner, Isabella; Hang, Yan; Mazur, Magdalena et al. (2010) MafA and MafB regulate genes critical to beta-cells in a unique temporal manner. Diabetes 59:2530-9
Masui, Toshihiko; Swift, Galvin H; Deering, Tye et al. (2010) Replacement of Rbpj with Rbpjl in the PTF1 complex controls the final maturation of pancreatic acinar cells. Gastroenterology 139:270-80

Showing the most recent 10 out of 24 publications